Elevated Plasma Levels of Interleukin-12p40 and Interleukin-16 in Overweight Adolescents

Lichtenauer, Michael; Franz, Marcus; Fritzenwanger, Michael; Figulla, Hans-Reiner; Gerdes, Norbert; Jung, Christian

doi:https://doi.org/10.1155/2015/940910

BioMed Research International

On this page

Abstract Introduction Methods Results Discussion Limitations Conclusion References Copyright Related Articles

Research Article | Open Access

Volume 2015 | Article ID 940910 | https://doi.org/10.1155/2015/940910

Elevated Plasma Levels of Interleukin-12p40 and Interleukin-16 in Overweight Adolescents

Michael Lichtenauer,¹Marcus Franz,²Michael Fritzenwanger,²Hans-Reiner Figulla,²Norbert Gerdes,³and Christian Jung²

Academic Editor: James D. Gorham

Received28 Oct 2014

Revised04 Dec 2014

Accepted06 Dec 2014

Published02 Feb 2015

Abstract

Introduction. Obesity during adolescence is an increasing problem for both the individual and health care systems alike. In Western world countries, childhood adiposity has reached epidemic proportions. It is known that elevated levels of proinflammatory cytokines can be found in the plasma of obese patients. In this study, we sought to determine the relation between IL-12p40, IL-12p70, and Interleukin-16 (IL-16) in overweight adolescents. Materials and Methods. Seventy-nine male Caucasian adolescents aged 13–17 years were included in this study. Thirty-seven of them had a body mass index (BMI) above the 90th age-specific percentile. Il-12p40, IL-12p70, and IL-16 were measured from plasma using Luminex multiplex technology. Results. Both IL-12p40 and IL-16 concentrations were significantly increased in overweight subjects compared to normal weight controls (IL-12p40: 1086.6 pg/mL ± 31.7 pg/mL SEM versus 1228.6 pg/mL ± 43.5 pg/mL SEM; IL-16 494.0 pg/mL ± 29.4 pg/mL SEM versus 686.6 pg/mL ± 52.5 pg/mL SEM, and , resp.). No differences were found for IL-12p70. Conclusions. Based on these results, we believe that the increased levels of IL-12p40 and IL-16 are associated with an ongoing inflammatory response in obese individuals and could lead to the development of disease conditions related to obesity.

1. Introduction

The development of obesity in children and adolescents has reached almost epidemic proportions in industrialized countries of the Western world since 1980. More than a fifth of all 12–19 year olds in the United States in 2012 were considered obese [1]. Adolescent adiposity is also closely related to persistent obesity in adult patients [2]. A plethora of studies has shown that higher body mass index (BMI) or other measures of obesity in children and adolescents are associated with adverse alterations of lipoprotein ratio, hypertension, insulin resistance, and diabetes [3, 4]. Moreover, abdominal obesity is also the hallmark for the metabolic syndrome (MS) as excess body weight is accompanied with hypertension, elevated blood glucose levels, and hyperlipidemia. Obesity also impairs the outcome in many chronic autoimmune diseases such as asthma.

The high prevalence of obesity in most Western countries also represents immense costs for health care systems. US studies showed that obesity in children is accompanied with higher hospitalization rates for comorbidities of obesity and drug prescription costs. Furthermore, it was shown that an elevated BMI was associated with 14.1 billion US dollars only for nonhospitalization expenditures [5].

Research of recent years showed that smoldering inflammatory processes in adipose tissue are present in overweight patients. Also in children, obesity was accompanied with higher concentrations of C-reactive protein indicating a low grade inflammatory state in these subjects [6].

This ongoing inflammation even at a low level could serve as an elicitor for endothelial stress reactions during the development of atherosclerosis over the years. This collectivization of permanent inflammation and endothelial dysfunction is causative for several cardiovascular pathologies such as coronary heart disease or hypertension which are more likely to occur in obese patients. A vast number of studies have investigated proinflammatory mediators like tumor-necrosis factor (TNF) or Interleukin-6 in adipose patients. However, the signaling axis via Interleukin-12 (IL-12) and Interleukin-16 (IL-16) has not yet received much attention in this context.

Here, we tried to examine the association of IL-12p40, IL-12p70, and IL-16 with obesity in a study cohort of overweight adolescents.

IL-12 is a major factor in early inflammatory responses and in the generation of T-helper type 1 (Th1) cells [7]. Elevated levels of IL-12 were thought to be related to the pathogenesis of autoimmune diseases associated with inflammatory reactions such as multiple sclerosis, arthritis, and insulin dependent diabetes [8–12]. Il-12 consists of a heavy chain (p40 subunit) and a light chain (p35 subunit) which are linked covalently by disulfide bonds to form the p70 molecule [13, 14]. Moreover, dendritic cells and macrophages were also shown to secrete the p40 subunit. The p40 subunit can also serve as a chemoattractant for macrophages [15] and dendritic cells [16] and induces the secretion of TNF-alpha and IL-16 in microglia cells and macrophages [17].

IL-16, also known as a leukocyte chemoattractant factor (LCF), is considered a proinflammatory cytokine and is produced by T-cells but also neutrophils and monocytes. It could promote migration of lymphocytes, induce the expression of proinflammatory factors, and modulate apoptosis. Moreover, peripheral blood mononuclear cells (PBMC), monocytes, and macrophages, but not CD4+ T-cells, were shown to secrete Interleukin-1beta, IL-6, and TNF-alpha upon stimulation with IL-16 [18].

The aim of this study was to investigate IL-12p40, IL-12p70, and IL-16 in overweight adolescents and their association with anthropometrical measurements of obesity.

2. Methods

2.1. Study Subjects

The experimental protocol for this study was approved by the local ethics committee (Friedrich-Schiller-University, Jena, Germany). All study subjects and their parents were provided with information on the course of the study and written informed consent was obtained. All experiments were performed in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice. In total, 79 voluntary male individuals aged 13–17 years going to schools in the area of greater Jena were included in this study. Of these, 37 (46%) had a body mass index (BMI) above the 90th percentile according to German charts [19]. After receipt of informed consent, the following parameters were recorded in one consultation: age, body height, body weight, heart rate, systolic and diastolic blood pressure, BMI, waist circumference, exercise rate (more or less than 3 hours per week), and family history of diabetes or cardiovascular disease. Waist circumference was measured as described previously [20]. In brief, waist circumference was measured during minimal respiration to the nearest 0.1 cm at the level of the iliac crest.

2.2. Blood Samples

All blood samples were collected by venipuncture from an antecubital vein using heparin and EDTA anticoagulated tubes in the morning after an overnight fast. The tubes were immediately processed and centrifuged within 60 minutes after blood withdrawal. Standard plasma parameters were obtained from the Department of Clinical Chemistry at the University Hospital Jena: high-density lipoprotein (HDL; mmol/L), low-density lipoprotein (LDL; mmol/L), triglycerides (mmol/L), C-reactive protein (CRP, mg/L; high sensitivity assay), and hematological parameters (e.g., counts for leukocytes and erythrocytes). Furthermore, aliquots of obtained plasma samples were stored at −80° until cytokine measurements were conducted.

2.3. Cytokine Measurements

The quantitative determination of human TNF-alpha, IL-6, IL-10, IL-12p40, IL-12p70, and IL-16 was performed from immediately frozen heparin plasma (−80° Celsius). Cytokine concentrations were determined using Bio-Plex technology according to the manufacturer’s instructions (Bio-Rad, Hercules, USA). Summarily, fluorescently dyed microspheres coated with capture antibodies bind to relevant cytokines in a sandwich immunoassay format. Unbound sample is removed in a washing step and a specific protein can be detected with a fluorescently labeled antibody. Quantitative measurements of cytokine levels were performed in a Luminex analyzer as previously described [21].

2.4. Statistical Analysis

Statistical analysis was performed using SPPS (21.0, SPSS Inc., USA) and GraphPad Prism software (GraphPad Software, USA). All data are given as mean ± standard error of the mean (SEM). IL-12p40, IL-12p70, and IL-16 concentrations between groups were compared using the Mann-Whitney test. Baseline characteristics were compared using the two-sided Student’s -test. In order to further explore the association between cytokines and patient characteristics, correlation analysis was performed (using Spearman correlation coefficient). The Bonferroni-Holm method was used to correct for multiple testing. values < 0.05 were considered statistically significant. A value of <0.05 was indicated as and a of < 0.01 as .

3. Results

Baseline characteristics for all 79 participants in this study are presented in Table 1 (see also [22–25]). Significant differences were found for weight, BMI, waist circumference, systolic blood pressure, erythrocytes, MCV, MCH, thrombocytes, monocytes, high sensitive C-reactive protein, HbA1c, creatinine, and high-density lipoprotein. As expected, overweight adolescents evidenced higher body weight, BMI, waist circumference, and lower high-density lipoprotein. Moreover, overweight subjects also showed higher levels of C-reactive protein indicating low grade inflammation.

Plasma concentration for both IL-12p40 and IL-16 was also significantly increased in the overweight group (Figure 1). In the control group, IL-12p40 was found at a concentration of 1086.6 pg/mL (±31.7 pg/mL SEM). IL-16 levels were 494.0 pg/mL (±29.4 pg/mL SEM). In overweight adolescents, IL-12p40 was increased to 1228.6 pg/mL (±43.5 pg/mL SEM, ) and IL-16 to 686.6 pg/mL (±52.5 pg/mL SEM, ). No differences were found for IL-12p70 (7.48 pg/mL ± 0.72 pg/mL SEM versus pg/mL SEM, ). Also no significant differences were found for TNF-alpha, IL-6, and IL-10 between the groups.

(a)

(b)

In order to further explore the association of IL-12p40 and IL-16 with subject parameters, we performed a correlation analysis. Correlations between clinical characteristics and IL-12p40 and IL-16 are depicted in Figures 2 and 3. IL-12p40 and IL-16 correlated significantly with anthropometrical parameters of obesity (body weight, BMI, and waist circumference). Of interest was that also a strong correlation to inflammatory and hematological parameters was found (Table 2). IL-12p70 did not correlate with baseline parameters. Moreover, the exercise rate of participating subjects did not correlate with IL-12p40 or IL-16 levels.

(a)

(b)

(c)

(a)

(b)

(c)

4. Discussion

Obesity strongly contributes to the development of cardiovascular pathologies and other morbidities such as diabetes. Primarily in Western world countries, the incidence of obesity is increasing over the last decades leading to many socioeconomic problems.

In obese patients, low grade inflammation is present as higher levels of proinflammatory cytokines were found in these individuals. With this current study, we aimed to expand the knowledge on cytokine regulation in obese adolescents with the main focus on the IL-12/IL-16 axis. As previous studies showed that IL-12p40 leads to increased secretion of IL-16 [17] which in turn further induced the release of many proinflammatory cytokines such as TNF-alpha and IL-6 from mononuclear cells, we believed that the regulatory mechanism between IL-12 and IL-16 signaling could be of greater importance in adipose children and adults.

We found that significantly higher concentrations of IL-12p40 and IL-16 but not IL-12p70 are present in the plasma of overweight adolescents. Levels of IL-12p40 and IL-16 correlated also significantly with anthropometrical measurements of obesity such as weight, BMI, and waist circumference. In this current study, we also analyzed serum concentrations of other cytokines, such as TNF-alpha, IL-6, and IL-10. However, levels of these cytokines did not differ significantly between groups.

Interestingly, relevant correlations were found when comparing levels of IL-12p40 and IL-16 with hematological parameters (leukocytes and neutrophils but not monocytes and lymphocytes). This could relate to the fact that slightly higher white blood cell counts were found in obese subjects. We hypothesized that the state of permanent low grade inflammation could be causative for these elevated levels of immune cells in the peripheral circulation as also higher levels of C-reactive protein were found. As IL-16 is mainly secreted by neutrophils, monocytes, dendritic cells [26], and CD8+ T-cells [27, 28], the higher number of these cell types could be also associated with the higher concentrations of IL-16 in the plasma of overweight probands. In one of our previous studies, we have shown that IL-16 is secreted in upon activation induced cell death by PBMC after coincubation with antithymocyte globulin [29]. IL-16 can cause the release of other proinflammatory cytokines and the process of ongoing inflammation is further substantiated in overweight patients subsequently leading to the progression of pathologies associated with adiposity.

Moreover, IL-16 is also involved in many autoimmune disease conditions [30] such as inflammatory bowel disease [31], rheumatoid arthritis [32], and airway hyperresponsiveness [33]. Many previous studies have determined a connection between childhood obesity and asthma [34, 35]. Obesity also increases the risk to develop rheumatoid arthritis [36]. In a mouse model of high-fat diet-induced obesity, it was shown that adiposity could lead to exacerbation of inflammatory bowel disease [37].

Interestingly, other prominent inflammatory mediators such as TNF-alpha and IL-6 showed no significant differences between the two study groups. One could speculate that the IL-12p40/IL-16 axis might be a more forefront proinflammatory signaling pathway in the earlier stages of obesity related disease conditions as they were likely present in our cohort of adolescents compared to the inflammatory milieu found in adult patients.

5. Limitations

Previous studies showed that IL-16 is upregulated within the adipose tissue of obese mice [38]. Based on our results, we cannot definitively distinguish the main origin of IL-16 as we only analyzed serum samples and not tissue samples of study subjects. Further studies are warranted in order to decode mechanisms leading to the expression of IL-12p40, IL-16, and other inflammatory factors in the context of obesity. It would be of great interest to identify cell types being the main source for the proinflammatory response in adipose patients. This knowledge would be of considerable importance to provide a better understanding of pathophysiological mechanisms induced by low grade inflammation and might help to develop new treatment strategies to counteract disease progression.

6. Conclusion

In summary, we conclude that the heightened levels of cytokines of the IL-12/IL-16 axis are involved in pathophysiological conditions that are found in overweight adolescents. Notably, IL-12p40 and IL-16 but not IL-12p70 are elevated in overweight adolescents, correlating with different anthropometrical parameters of obesity. Increased levels of these mediators could lead to the progression of diseases associated with obesity and the metabolic syndrome.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

C. L. Ogden, M. D. Carroll, B. K. Kit, and K. M. Flegal, “Prevalence of childhood and adult obesity in the United States, 2011–2012,” The Journal of the American Medical Association, vol. 311, no. 8, pp. 806–814, 2014.
View at: Publisher Site | Google Scholar
N. S. The, C. Suchindran, K. E. North, B. M. Popkin, and P. Gordon-Larsen, “Association of adolescent obesity with risk of severe obesity in adulthood,” JAMA—Journal of the American Medical Association, vol. 304, no. 18, pp. 2042–2047, 2010.
View at: Publisher Site | Google Scholar
A. S. Kelly, S. E. Barlow, G. Rao et al., “Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association,” Circulation, vol. 128, no. 15, pp. 1689–1712, 2013.
View at: Publisher Site | Google Scholar
A. Reich, G. Müller, G. Gelbrich, K. Deutscher, R. Gödicke, and W. Kiess, “Obesity and blood pressure—results from the examination of 2365 schoolchildren in Germany,” International Journal of Obesity, vol. 27, no. 12, pp. 1459–1464, 2003.
View at: Publisher Site | Google Scholar
L. Trasande, Y. Liu, G. Fryer, and M. Weitzman, “Effects of childhood obesity on hospital care and costs, 1999–2005,” Health Affairs, vol. 28, no. 4, pp. w751–w760, 2009.
View at: Publisher Site | Google Scholar
G. Akinci, S. Coskun, B. Akinci et al., “Atherosclerosis risk factors in children of parents with the metabolic syndrome,” Atherosclerosis, vol. 194, no. 2, pp. e165–e171, 2007.
View at: Publisher Site | Google Scholar
C.-S. Hsieh, S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy, “Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages,” Science, vol. 260, no. 5107, pp. 547–548, 1993.
View at: Publisher Site | Google Scholar
D. M. Calida, S. G. Kremlev, T. Fujioka et al., “Experimental allergic neuritis in the SJL/J mouse: Induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12,” Journal of Neuroimmunology, vol. 107, no. 1, pp. 1–7, 2000.
View at: Publisher Site | Google Scholar
C. S. Constantinescu, D. B. P. Goodman, B. Hilliard, M. Wysocka, and J. A. Cohen, “Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products,” Neuroscience Letters, vol. 287, no. 3, pp. 171–174, 2000.
View at: Publisher Site | Google Scholar
D. Zipris, D. L. Greiner, S. Malkani, B. Whalen, J. P. Mordes, and A. A. Rossini, “Cytokine gene expression in islets and thyroids of BB rats. IFN-γ and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats,” The Journal of Immunology, vol. 156, no. 3, pp. 1315–1321, 1996.
View at: Google Scholar
R. M. Pope and S. Shahrara, “Possible roles of IL-12-family cytokines in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 9, no. 4, pp. 252–256, 2013.
View at: Publisher Site | Google Scholar
A. A. Ebrahimi, H. Noshad, S. Sadreddini et al., “Serum levels of TNF-α, TNF-αRI, TNF-αRII and IL-12 in treated rheumatoid arthritis patients,” Iranian Journal of Immunology, vol. 6, no. 3, pp. 147–153, 2009.
View at: Google Scholar
D. S. Schoenhaut, A. O. Chua, A. G. Wolitzky et al., “Cloning and expression of murine IL-12,” The Journal of Immunology, vol. 148, no. 11, pp. 3433–3440, 1992.
View at: Google Scholar
S. F. Wolf, P. A. Temple, M. Kobayashi et al., “Cloning of cDNA for natural killer cell stimulatory factor, A heterodimeric cytokine with multiple biologic effects on T and natural killer cells,” Journal of Immunology, vol. 146, no. 9, pp. 3074–3081, 1991.
View at: Google Scholar
A. M. Cooper and S. A. Khader, “IL-12p40: an inherently agonistic cytokine,” Trends in Immunology, vol. 28, no. 1, pp. 33–38, 2007.
View at: Publisher Site | Google Scholar
S. A. Khader, S. Partida-Sanchez, G. Bell et al., “Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 203, no. 7, pp. 1805–1815, 2006.
View at: Publisher Site | Google Scholar
M. Jana and K. Pahan, “IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages,” Molecular Immunology, vol. 46, no. 5, pp. 773–783, 2009.
View at: Publisher Site | Google Scholar
N. L. Mathy, W. Scheuer, M. Lanzendörfer et al., “Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes,” Immunology, vol. 100, no. 1, pp. 63–69, 2000.
View at: Publisher Site | Google Scholar
K. Kromeyer-Hauschild, M. Wabitsch, D. Kunze et al., “Perzentile für den body-mass-index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben,” Monatsschrift für Kinderheilkunde, vol. 149, no. 8, pp. 807–818, 2011.
View at: Publisher Site | Google Scholar
P. M. Janiszewski, I. Janssen, and R. Ross, “Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors?” Diabetes Care, vol. 30, no. 12, pp. 3105–3109, 2007.
View at: Publisher Site | Google Scholar
I. H. Khan, V. V. Krishnan, M. Ziman et al., “Comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients,” Cytometry Part B: Clinical Cytometry, vol. 76, no. 3, pp. 159–168, 2009.
View at: Publisher Site | Google Scholar
C. Jung, N. Gerdes, M. Fritzenwanger, and H. R. Figulla, “Circulating levels of interleukin-1 family cytokines in overweight adolescents,” Mediators of Inflammation, vol. 2010, Article ID 958403, 6 pages, 2010.
View at: Publisher Site | Google Scholar
C. Jung, N. Fischer, M. Fritzenwanger et al., “Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age,” Clinical Research in Cardiology, vol. 98, no. 3, pp. 179–188, 2009.
View at: Publisher Site | Google Scholar
C. Jung, N. Fischer, M. Fritzenwanger, J. Pernow, B. R. Brehm, and H. R. Figulla, “Association of waist circumference, traditional cardiovascular risk factors, and stromal-derived factor-1 in adolescents,” Pediatric Diabetes, vol. 10, no. 5, pp. 329–335, 2009.
View at: Publisher Site | Google Scholar
C. Jung, N. Fischer, M. Fritzenwanger, and H. R. Figulla, “Anthropometric indices as predictors of the metabolic syndrome and its components in adolescents,” Pediatrics International, vol. 52, no. 3, pp. 402–409, 2010.
View at: Publisher Site | Google Scholar
K. Reich, S. Hugo, P. Middel, V. Blaschke, A. Heine, and C. Neumann, “The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-α and IL-1β,” Experimental Dermatology, vol. 13, no. 12, pp. 740–747, 2004.
View at: Publisher Site | Google Scholar
J. M. Schwab, T. D. Nguyen, R. Meyermann, and H. J. Schluesener, “Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8⁺ T-lymphocytes and activated microglia/macrophages,” Journal of Neuroimmunology, vol. 114, no. 1-2, pp. 232–241, 2001.
View at: Publisher Site | Google Scholar
S. Laberge, W. W. Cruikshank, H. Kornfeld, and D. M. Center, “Histamine-induced secretion of lymphocyte chemoattractant factor from CD8⁺ T cells is independent of transcription and translation: evidence for constitutive protein synthesis and storage,” Journal of Immunology, vol. 155, no. 6, pp. 2902–2910, 1995.
View at: Google Scholar
M. Lichtenauer, M. Mildner, G. Werba et al., “Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction,” PLoS ONE, vol. 7, no. 12, Article ID e52101, 2012.
View at: Publisher Site | Google Scholar
M. Versini, P. Y. Jeandel, E. Rosenthal, and Y. Shoenfeld, “Obesity in autoimmune diseases: not a passive bystander,” Autoimmunity Reviews, vol. 13, pp. 981–1000, 2014.
View at: Google Scholar
D. Seegert, P. Rosenstiel, H. Pfahler, P. Pfefferkorn, S. Nikolaus, and S. Schreiber, “Increased expression of IL-16 in inflammatory bowel disease,” Gut, vol. 48, no. 3, pp. 326–332, 2001.
View at: Publisher Site | Google Scholar
J. K. Franz, S. A. Kolb, K. M. Hummel et al., “Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis,” European Journal of Immunology, vol. 28, no. 9, pp. 2661–2671, 1998.
View at: Google Scholar
E. M. Hessel, W. W. Cruikshank, I. van Ark et al., “Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma,” The Journal of Immunology, vol. 160, no. 6, pp. 2998–3005, 1998.
View at: Google Scholar
C. Papoutsakis, M. Chondronikola, G. Antonogeorgos et al., “Associations between central obesity and asthma in children and adolescents: a case control study,” The Journal of Asthma, 2014.
View at: Publisher Site | Google Scholar
D. Raj, S. K. Kabra, and R. Lodha, “Childhood obesity and risk of allergy or asthma,” Immunology and Allergy Clinics of North America, vol. 34, pp. 753–765, 2014.
View at: Google Scholar
C. S. Crowson, E. L. Matteson, J. M. Davis III, and S. E. Gabriel, “Contribution of obesity to the rise in incidence of rheumatoid arthritis,” Arthritis Care & Research, vol. 65, no. 1, pp. 71–77, 2013.
View at: Publisher Site | Google Scholar
J. Paik, Y. Fierce, P. Treuting, T. Brabb, and L. Maggio-Price, “High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible mdr1a^{^-/-} male mice,” The Journal of Nutrition, vol. 143, no. 8, pp. 1240–1247, 2013.
View at: Publisher Site | Google Scholar
E. Kurki, J. Shi, E. Martonen, P. Finckenberg, and E. Mervaala, “Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice,” Nutrition and Metabolism, vol. 9, article 64, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2015 Michael Lichtenauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1959

Downloads

797

Citations